VIR Earnings Vir Biotechnology, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–30 of 30
| Q2 2026 | 2026-06-30 | -0.29 | 2026-08-05 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.85 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -3.16 | 2026-02-23 | 10-K |
| Q3 2025 | 2025-09-30 | -2.86 | 2025-11-05 | 10-Q |
| Q2 2026 | 2025-06-30 | -1.68 | 2026-08-05 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.88 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -3.83 | 2026-02-23 | 10-K |
| Q3 2025 | 2024-09-30 | -3.07 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.50 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.48 | 2025-05-08 | 10-Q |
| FY 2025 | 2023-12-31 | -4.59 | 2026-02-23 | 10-K |
| Q3 2024 | 2023-09-30 | -3.73 | 2024-11-04 | 10-Q |
| Q2 2024 | 2023-06-30 | -2.51 | 2024-08-01 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.06 | 2024-05-03 | 10-Q |
| FY 2024 | 2022-12-31 | 3.83 | 2025-02-27 | 10-K |
| Q3 2023 | 2022-09-30 | 4.58 | 2023-11-03 | 10-Q |
| Q2 2023 | 2022-06-30 | 3.28 | 2023-08-04 | 10-Q |
| Q1 2023 | 2022-03-31 | 3.85 | 2023-05-08 | 10-Q |
| FY 2023 | 2021-12-31 | 3.96 | 2024-02-26 | 10-K |
| Q3 2022 | 2021-09-30 | 0.02 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.83 | 2022-08-09 | 10-Q |
| Q1 2022 | 2021-03-31 | -1.32 | 2022-05-05 | 10-Q |
| FY 2022 | 2020-12-31 | -2.51 | 2023-02-28 | 10-K |
| Q3 2021 | 2020-09-30 | -1.66 | 2021-11-04 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.97 | 2021-08-05 | 10-Q |
| FY 2020 | 2020-03-31 | -0.71 | 2021-02-25 | 10-K |
| FY 2021 | 2019-12-31 | -5.76 | 2022-02-28 | 10-K |
| FY 2020 | 2019-09-30 | -4.60 | 2021-02-25 | 10-K |
| FY 2020 | 2019-06-30 | -3.64 | 2021-02-25 | 10-K |
| FY 2020 | 2019-03-31 | -3.19 | 2021-02-25 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.